Literature DB >> 19760861

Intraoperative and postoperative complications of nephron sparing surgery: prevention and possible treatments.

Giorgio Pomara1, Giuseppe Campo, Francesco Francesca.   

Abstract

Conservative surgery for renal cell carcinoma has been widely diffused and performed in the last 15 years. It showed excellent oncological results in imperative and then elective indications. A greater number of small renal lesions are now being discovered, and elective partial nephrectomy has been adopted more frequently for the treatment of such tumours. However results regarding morbidity are extremely variable in the literature and the overall complication rate after NSS ranges between 4% and 30%. Fortunately, better patient selection, operating techniques, perioperative care, and surgical experience have guaranteed a significant reduction of complication in the last decade. The purpose of this review was to assess the incidence of complications of conservative renal surgery for renal cell carcinoma and to discuss treatment modalities.

Entities:  

Mesh:

Year:  2009        PMID: 19760861

Source DB:  PubMed          Journal:  Arch Ital Urol Androl        ISSN: 1124-3562


  2 in total

1.  A novel method for texture-mapping conoscopic surfaces for minimally invasive image-guided kidney surgery.

Authors:  Rowena Ong; Courtenay L Glisson; Jessica Burgner-Kahrs; Amber Simpson; Andrei Danilchenko; Ray Lathrop; S Duke Herrell; Robert J Webster; Michael Miga; Robert L Galloway
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-01-13       Impact factor: 2.924

2.  Open versus robotic-assisted partial nephrectomy: a multicenter comparison study of perioperative results and complications.

Authors:  Andrea Minervini; Gianni Vittori; Alessandro Antonelli; Antonio Celia; Simone Crivellaro; Donato Dente; Vincenzo Di Santo; Bruno Frea; Mauro Gacci; Alberto Gritti; Lorenzo Masieri; Alessandro Morlacco; Angelo Porreca; Bernardo Rocco; Paolo Parma; Claudio Simeone; Stefano Zaramella; Marco Carini; Sergio Serni
Journal:  World J Urol       Date:  2013-08-04       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.